About Omkar Pharmachem Limited
Data last updated: 15 July 2026
Omkar Pharmachem Limited is a public limited company based in Ahmedabad, Gujarat, India. It specialises in pharmaceutical retail and distribution, a part of the broader pharmaceuticals sector. Incorporated on 31 March 1995, the company has been in operation for over 31 years.
Registered with ROC Ahmedabad under CIN L93000GJ1995PLC025276. Listed on BSE: 532167.
Capital: an authorised share capital of ₹10.5 Cr and a paid-up capital of ₹10.08 Cr. It is led by directors including Parminder Sharma and Bhawani Shankar Goyal.
Last AGM: 24 September 2025. Financial statements filed for year ended 31 March 2025. Office: 310 Wall Street – 1 Near Gujarat College Cross Road Ellisbr, Idge, Ahmedabad, Gujarat, India – 380006.
As per BSE-filed standalone financials for FY 2026, the company reported a revenue of ₹46.5 Lakh, a decline of 13.89% compared to the previous year. The net worth stands at ₹36.64 Cr (up 288.39% YoY). Total assets are valued at ₹36.69 Cr (up 282.06% YoY).
As per MCA filings, the company has satisfied charges of ₹10.89 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website omkarpharmachem.co.in.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered Address310 Wall Street – 1 Near Gujarat College Cross Road Ellisbr, Idge, Ahmedabad, Gujarat, India – 380006
-
IndustryPharma, Pharmaceutical Retailers & Distributors
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Omkar Pharmachem Limited
Omkar Pharmachem Limited has one previous CIN (Corporate Identification Number): L24231GJ1995PLC025276. The current CIN is L93000GJ1995PLC025276, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L93000GJ1995PLC025276 | Current |
| L24231GJ1995PLC025276 | Previous |
Business Activity of Omkar Pharmachem Limited
Omkar Pharmachem Limited is engaged in the principal business activity of support service to organizations, with detailed activities including other support services to organizations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations | Locked |
Business activity turnover details for Omkar Pharmachem Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Omkar Pharmachem Limited
Omkar Pharmachem Limited is audited by Dipal R Shah & Co. (ICAI peer reviewed, certificate valid till 2026-08-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| Dipal R Shah & Co. (ICAI peer reviewed, certificate valid till 2026-08-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Omkar Pharmachem Limited
Omkar Pharmachem Limited is currently managed by 4 directors, with 13 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Parminder Sharma
Also directs:
Omkar Pharmachem Limited, Wave Infradevelopers Private Limited, Opportunity Developers Private Limited and 2 more
|
Director | 14 Nov 2003 | 22 Years 9 Months | Current |
| Bhawani Shankar Goyal | Managing Director | 14 Feb 2020 | 6 Years 6 Months | Current |
| Surjeet Kaur | Director | 28 Jun 2025 | 1 Years 2 Months | Current |
|
Anupam Kumar Mishra
Also directs:
Omkar Pharmachem Limited
|
Director | 27 Aug 2025 | 1 Years 0 Months | Current |
Financials of Omkar Pharmachem Limited FY 2026 filings available
Omkar Pharmachem Limited reported revenue of ₹46.5 Lakh (down 13.89% YoY) for FY 2026.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹46.5 Lakh | ₹54 Lakh | ₹54 Lakh | ₹54 Lakh | ₹54 Lakh | ₹27 Lakh | ₹4.5 Lakh | ₹0 |
| Other Income | ₹74,000 | ₹22,000 | ₹35,000 | ₹30,000 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Income | ₹47.24 Lakh | ₹54.22 Lakh | ₹54.35 Lakh | ₹54.3 Lakh | ₹54 Lakh | ₹27 Lakh | ₹4.5 Lakh | ₹0 |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹20.86 Lakh | ₹16.07 Lakh | ₹15.79 Lakh | ₹13.87 Lakh | ₹17.49 Lakh | ₹15.16 Lakh | ₹15.27 Lakh | ₹19.06 Lakh |
| Finance Costs | ₹21,000 | ₹1.71 Lakh | ₹2.91 Lakh | ₹4.63 Lakh | ₹5.58 Lakh | ₹5.67 Lakh | ₹5.33 Lakh | ₹3.74 Lakh |
| Depreciation & Amortisation | ₹33,000 | ₹51,000 | ₹49,000 | ₹27,000 | ₹19,000 | ₹10,000 | ₹19,000 | ₹35,000 |
| Other Expenses | ₹9.56 Lakh | ₹8.93 Lakh | ₹9.88 Lakh | ₹9.08 Lakh | ₹9.69 Lakh | ₹9.66 Lakh | ₹9.67 Lakh | ₹18.91 Lakh |
| Total Expenses | ₹30.96 Lakh | ₹27.22 Lakh | ₹29.07 Lakh | ₹27.85 Lakh | ₹32.95 Lakh | ₹30.59 Lakh | ₹30.46 Lakh | ₹42.06 Lakh |
| Profit Before Exceptional Items & Tax | ₹16.28 Lakh | ₹27 Lakh | ₹25.28 Lakh | ₹26.45 Lakh | ₹21.05 Lakh | -₹3.59 Lakh | -₹25.96 Lakh | -₹42.06 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹16.28 Lakh | ₹27 Lakh | ₹25.28 Lakh | ₹26.45 Lakh | ₹21.05 Lakh | -₹3.59 Lakh | -₹25.96 Lakh | -₹42.06 Lakh |
| Total Tax Expense | ₹4.1 Lakh | ₹6.91 Lakh | ₹6.37 Lakh | ₹6.67 Lakh | ₹2.74 Lakh | -₹25.73 Lakh | ₹0 | -₹4,000 |
| Net Profit | ₹12.18 Lakh | ₹20.09 Lakh | ₹18.91 Lakh | ₹19.78 Lakh | ₹18.31 Lakh | ₹22.14 Lakh | -₹25.96 Lakh | -₹42.02 Lakh |
| Other Comprehensive Income | ₹27.08 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹27.21 Cr | ₹20.09 Lakh | ₹18.91 Lakh | ₹19.78 Lakh | ₹18.31 Lakh | ₹22.14 Lakh | -₹25.96 Lakh | -₹42.02 Lakh |
| EBITDA (computed) | ₹16.82 Lakh | ₹29.22 Lakh | ₹28.68 Lakh | ₹31.35 Lakh | ₹26.82 Lakh | ₹2.18 Lakh | -₹20.44 Lakh | -₹37.97 Lakh |
| Basic EPS | ₹26.98 | ₹0.20 | ₹0.19 | ₹0.20 | ₹0.18 | ₹0.21 | ₹-0.26 | ₹-0.42 |
| Diluted EPS | ₹26.98 | ₹0.20 | ₹0.19 | ₹0.20 | ₹0.18 | ₹0.21 | ₹-0.26 | ₹-0.42 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹36.69 Cr | ₹9.6 Cr | ₹9.59 Cr | ₹9.73 Cr | ₹9.83 Cr | ₹9.63 Cr | ₹9.36 Cr | ₹9.32 Cr |
| Non-current Assets | ₹36.39 Cr | ₹9.34 Cr | ₹9.41 Cr | ₹9.47 Cr | ₹9.54 Cr | ₹9.56 Cr | ₹9.3 Cr | ₹9.3 Cr |
| Current Assets | ₹30.14 Lakh | ₹26.51 Lakh | ₹18.41 Lakh | ₹26.23 Lakh | ₹29.24 Lakh | ₹7.09 Lakh | ₹5.88 Lakh | ₹2.03 Lakh |
| Property, Plant & Equipment | ₹37,000 | ₹70,000 | ₹81,000 | ₹37,000 | ₹64,000 | ₹15,000 | ₹25,000 | ₹30,000 |
| Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Trade Receivables | ₹3.24 Lakh | ₹9.72 Lakh | ₹4.76 Lakh | ₹12.96 Lakh | ₹8.1 Lakh | ₹2.7 Lakh | ₹1.8 Lakh | ₹0 |
| Cash & Equivalents | ₹21.73 Lakh | ₹10.94 Lakh | ₹7.16 Lakh | ₹13.27 Lakh | ₹21.14 Lakh | ₹4.39 Lakh | ₹4.08 Lakh | ₹2.03 Lakh |
| Equity (Net Worth) | ₹36.64 Cr | ₹9.43 Cr | ₹9.23 Cr | ₹9.04 Cr | ₹8.85 Cr | ₹8.66 Cr | ₹8.44 Cr | ₹8.7 Cr |
| Equity Share Capital | ₹10.08 Cr | ₹10.08 Cr | ₹10.08 Cr | ₹10.08 Cr | ₹10.08 Cr | ₹10.08 Cr | ₹10.08 Cr | ₹10.08 Cr |
| Borrowings (Non-current) | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Borrowings (Current) | ₹0 | ₹11.85 Lakh | ₹30.31 Lakh | ₹62.14 Lakh | ₹92.97 Lakh | ₹90.24 Lakh | ₹86.55 Lakh | ₹57.73 Lakh |
| Total Debt (computed) | ₹0 | ₹11.85 Lakh | ₹30.31 Lakh | ₹62.14 Lakh | ₹92.97 Lakh | ₹90.24 Lakh | ₹86.55 Lakh | ₹57.73 Lakh |
| Current Liabilities | ₹5.06 Lakh | ₹16.96 Lakh | ₹35.53 Lakh | ₹68.62 Lakh | ₹98.36 Lakh | ₹96.76 Lakh | ₹92.06 Lakh | ₹62.29 Lakh |
| Total Liabilities | ₹5.06 Lakh | ₹16.96 Lakh | ₹35.96 Lakh | ₹68.62 Lakh | ₹98.36 Lakh | ₹96.76 Lakh | ₹92.06 Lakh | ₹62.29 Lakh |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹22.85 Lakh | ₹24.35 Lakh | ₹29.56 Lakh | ₹27.59 Lakh | ₹20.28 Lakh |
| Investing Cash Flow | ₹0 | -₹40,000 | -₹93,000 | ₹0 | -₹68,000 |
| Financing Cash Flow | -₹12.06 Lakh | -₹20.17 Lakh | -₹34.74 Lakh | -₹35.46 Lakh | -₹2.85 Lakh |
| Capital Expenditure | ₹0 | ₹40,000 | ₹93,000 | ₹0 | ₹68,000 |
| Free Cash Flow (computed) | ₹22.85 Lakh | ₹23.95 Lakh | ₹28.63 Lakh | ₹27.59 Lakh | ₹19.6 Lakh |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | ₹10.79 Lakh | ₹3.78 Lakh | -₹6.11 Lakh | -₹7.87 Lakh | ₹16.75 Lakh |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹9 Lakh | ₹10.5 Lakh | ₹13.5 Lakh | ₹13.5 Lakh | ₹13.5 Lakh | ₹13.5 Lakh | ₹13.5 Lakh | ₹13.5 Lakh |
| Other Income | ₹30,000 | ₹0 | ₹44,000 | ₹0 | ₹0 | ₹22,000 | ₹0 | ₹0 |
| Total Income | ₹9.3 Lakh | ₹10.5 Lakh | ₹13.94 Lakh | ₹13.5 Lakh | ₹13.5 Lakh | ₹13.72 Lakh | ₹13.5 Lakh | ₹13.5 Lakh |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹5.14 Lakh | ₹5.43 Lakh | ₹5.36 Lakh | ₹4.93 Lakh | ₹4.72 Lakh | ₹4.2 Lakh | ₹3.37 Lakh | ₹3.78 Lakh |
| Finance Costs | ₹0 | ₹0 | ₹21,000 | ₹0 | ₹1.71 Lakh | ₹0 | ₹0 | ₹0 |
| Depreciation & Amortisation | ₹8,000 | ₹8,000 | ₹8,000 | ₹8,000 | ₹15,000 | ₹15,000 | ₹12,000 | ₹9,000 |
| Other Expenses | ₹2.13 Lakh | ₹1.03 Lakh | ₹1.49 Lakh | ₹4.91 Lakh | ₹2.16 Lakh | ₹88,000 | ₹1.16 Lakh | ₹4.73 Lakh |
| Total Expenses | ₹7.35 Lakh | ₹6.54 Lakh | ₹7.14 Lakh | ₹9.92 Lakh | ₹8.74 Lakh | ₹5.23 Lakh | ₹4.65 Lakh | ₹8.6 Lakh |
| Profit Before Exceptional Items & Tax | ₹1.95 Lakh | ₹3.96 Lakh | ₹6.8 Lakh | ₹3.58 Lakh | ₹4.76 Lakh | ₹8.49 Lakh | ₹8.85 Lakh | ₹4.9 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹1.95 Lakh | ₹3.96 Lakh | ₹6.8 Lakh | ₹3.58 Lakh | ₹4.76 Lakh | ₹8.49 Lakh | ₹8.85 Lakh | ₹4.9 Lakh |
| Total Tax Expense | ₹45,000 | ₹1.01 Lakh | ₹1.73 Lakh | ₹92,000 | ₹6.91 Lakh | ₹0 | ₹0 | ₹0 |
| Net Profit | ₹1.5 Lakh | ₹2.95 Lakh | ₹5.07 Lakh | ₹2.66 Lakh | -₹2.15 Lakh | ₹8.49 Lakh | ₹8.85 Lakh | ₹4.9 Lakh |
| Other Comprehensive Income | ₹27.08 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹27.1 Cr | ₹2.95 Lakh | ₹5.07 Lakh | ₹2.66 Lakh | -₹2.15 Lakh | ₹8.49 Lakh | ₹8.85 Lakh | ₹4.9 Lakh |
| EBITDA (computed) | ₹2.03 Lakh | ₹4.04 Lakh | ₹7.09 Lakh | ₹3.66 Lakh | ₹6.62 Lakh | ₹8.64 Lakh | ₹8.97 Lakh | ₹4.99 Lakh |
| Basic EPS | ₹26.87 | ₹0.03 | ₹0.05 | ₹0.02 | ₹-0.02 | ₹0.08 | ₹0.09 | ₹0.05 |
| Diluted EPS | ₹26.87 | ₹0.03 | ₹0.05 | ₹0.02 | ₹-0.02 | ₹0.08 | ₹0.09 | ₹0.05 |
Shareholding Pattern of Omkar Pharmachem Limited
As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 0.03%, retail and other public shareholders hold 99.97% of Omkar Pharmachem Limited. The company had 3,617 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% |
| Public | 99.97% | 99.97% | 99.97% | 99.97% | 99.97% | 99.97% |
| Mar 2026 | Mar 2025 | Mar 2024 | |
|---|---|---|---|
| Promoters | 0.03% | 0.03% | 0.03% |
| Public | 99.97% | 99.97% | 99.97% |
| Promoter change (YoY, %pts) | +0.00 | +0.00 | - |
Charges & Borrowings of Omkar Pharmachem Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 May 1995 | Gujarat State Financial Co-Op | ₹10.89 Lakh | Satisfied |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Omkar Pharmachem Limited
View historical data on people associated with Omkar Pharmachem Limited, including employment history and EPFO contributions.
Employee and EPFO history for Omkar Pharmachem Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Omkar Pharmachem Limited
GST registrations and filing compliance for Omkar Pharmachem Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Omkar Pharmachem Limited
Credit ratings, litigation, and regulatory alerts for Omkar Pharmachem Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Omkar Pharmachem Limited
MSME payment history for Omkar Pharmachem Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Omkar Pharmachem Limited
Corporate group structure for Omkar Pharmachem Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Omkar Pharmachem Limited
MCA filings and documents for Omkar Pharmachem Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Omkar Pharmachem Limited
Frequently Asked Questions about Omkar Pharmachem Limited
Omkar Pharmachem Limited is an active public limited company in the pharma sector based in Ahmedabad, Gujarat, India. It was incorporated on 31 March 1995 (31+ years old) and is registered under CIN L93000GJ1995PLC025276. Listed on BSE: 532167.
Omkar Pharmachem Limited reported revenue of ₹46.5 Lakh for FY 2026 (down 13.89% YoY) based on standalone BSE filings.
The current directors of Omkar Pharmachem Limited are:
- Parminder Sharma - Director
- Bhawani Shankar Goyal - Managing Director
- Surjeet Kaur - Director
- Anupam Kumar Mishra - Director
The primary industry of Omkar Pharmachem Limited is pharma. The company specifically operates in pharmaceutical retailers and distributors. The company is currently active in this sector.
Yes. Omkar Pharmachem Limited is listed on BSE with code 532167.
Omkar Pharmachem Limited can be reached at the registered office: 310 Wall Street – 1 Near Gujarat College Cross Road Ellisbr, Idge, Ahmedabad, Gujarat, India – 380006, or through the website omkarpharmachem.co.in.